Senators reveal how much Lilly, Pfizer paid telehealth companies

Taking stock of the drug industry, from the lab to the medicine chest

July 24, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Molly Ferguson/STAT STAT+ | Why Sarepta may not survive its current gene therapy crisis  In this edition of "Adam's Biotech Scorecard," Adam also looks at the situation facing Sarepta's CEO, whose job is now on the line because of Elevydis. By Adam Feuerstein STAT+ | For many Duchenne families, halt to gene therapy is heartbreak upon heartbreak A muscular dystrophy disease is devastating on its own, but Sarepta Therapeutics' Elevydis, currently shelved, had offered hope. By Jason Mast STAT+ | Opinion: Alnylam CEO: Congress must pass the MINI Act to protect future biotech breakthroughs A technical oversight in the Inflation Reduction Act is making it much harder for biotech companies to pursue genetically targeted therapies, writes Alnylam CEO. By Yvonne Greenstreet ADOBE Opinion: How states can mitigate Trump's Medicaid cuts – and set their health care systems on a better path States can minimize federal Medicaid cuts and even set their health care systems on a better long-term trajectory. By Hayden Rooke-Ley Researchers sequence complex parts of human genome, expanding the future of precision medicine "Landmark" study published in Nature solves 92% of missing data in the human genome, offers unprecedented map of genomic variation across ancestries. By Veronica Paulus

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser